Long COVID: Mechanisms, Risk Factors, and Recovery

External Event - 22nd to 23rd Feb 2022

Online Conference

This innovative two-day conference will review the challenges of understanding the pathophysiological changes following COVID-19 infection. These persistent symptoms following SARS-CoV-2 infection, otherwise known as long COVID, have affected people all around the world. It is a heterogeneous disease with multimorbidities and affecting many physiological systems.

Bringing together physiologists and clinicians, we can better understand the underlying mechanisms and identify potential therapies.

A snapshot of the sessions on offer: 

• Characterising long COVID: What is it? 
• Risk factors: Why do some people get Long COVID and not others? 
• Impact of fong COVID on active individuals: Athletics and military perspective 
• Mechanisms of long COVID 
• Treatments for long COVID 
• Ideas exchange in our panel discussions 

Programme

22nd February

Session 1: Characterising Long COVID: What is it?

Invited speaker presentations followed by a panel discussion

Speakers include Dr Liz Ford (University of Sussex, UK).

Flash talks from submissions

Session 2: Risk Factors - Why Do Some People Get Long COVID and Not Others?

Invited speaker presentations followed by a panel discussion

Speakers include Professor Danny Altmann (Imperial College London, UK), and Dr Maxime Taquet (University of Oxford, UK).

Session 3: Impact of Long COVID on Active Individuals: Athletics and Military Perspective

Invited speaker presentations followed by a panel discussion

Speakers include Dr Oliver O’Sullivan (Ministry of Defence, UK), Dr James Hull (Royal Brompton Hospital, UK), and Professor Melitta McNarry (University of Swansea, UK).

23th February

Session 1: Mechanisms of Long COVID

Invited speaker presentations followed by a panel discussion

Speakers include Dr Melanie Dani (Imperial College London, UK), Dr Boon Lim (Imperial College London, UK), Dr Karl Morten (University of Oxford, UK), Professor Resia Pretorius (Stellenbosch University, South Africa).

Posters and small group discussions

Session 2: Treatments for Long COVID

Invited speaker presentations followed by a panel discussion

Speakers include Professor Amitava Banerjee (University College London, UK).

Session 3: The Future of Long COVID Research

Patient perspectives and interactive workshop on future priorities for COVID research.